Tradestie Institutional Equity Comparison Engine

AQST vs LVTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AQST Overall Edge

AQST Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aquestive Therapeutics, Inc. Common Stock (AQST) driven by superior Growth & Margin, Options & Structure while LVTX counters with relative strength in Momentum & Technical. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus LVTX at N/M Forward P/E and -431.9% operating margin (+1313.6% YoY). In options structure, AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro) against LVTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AQST N/M vs LVTX N/M Fwd P/E
Growth & Margin Winner AQST
Op Margin -114.1% vs -431.9% ยท YoY -41.0% vs +1313.6%
Momentum & Technical Winner LVTX
1Y -40.6% vs +17.6% ยท 52W Pos 14% vs 77%
Options & Structure Winner AQST
BREAKDOWN (64th %ile IV) vs UNCLASSIFIED (N/A IV)
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.46
-6.61% 1D
Market Cap $465.7M
1M Return -16.22%
1Y Return -40.65%
Forward P/E N/M
Unified AI Score
62.9 / 100 BUY
Tech 54.0 Fund 68.0 Flow 68.0 Mom 60.0
LVTX NASDAQ
LAVA Therapeutics N.V. Ordinary Shares
Pharmaceutical Preparations
$1.74
-3.87% 1D
Market Cap $45.8M
1M Return +6.75%
1Y Return +17.57%
Forward P/E N/M
Unified AI Score
67.0 / 100 BUY
Tech 75.0 Fund 63.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AQST -40.65% LVTX +17.57% Spread: +0.27 pp (AQST Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AQST TTM Op. Margin: -114.1% LVTX TTM Op. Margin: -431.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AQST vs LVTX. Trailing 12-month operating profitability (AQST -114.1% vs LVTX -431.9%) and valuation multiples (AQST N/M vs LVTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AQST (3) vs LVTX (5)
Institutional Metric AQST LVTX Criterion Row Winner
Market Capitalization Scale $465.7M $45.8M Larger Scale AQST
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -41.0% +1313.6% Higher Growth LVTX
Operating Margin (TTM) Profitability -114.1% -431.9% Higher Margin AQST
Net Profit Margin Profitability -162.3% 0.0% Higher Margin LVTX
Return on Equity (ROE) Capital Efficiency 0.0% -101.5% Higher ROE AQST
52-Week Range Position Momentum 14% ($3โ€“$7) 77% ($1โ€“$2) Stronger Trend LVTX
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 56% Vol -0.02ฮฒ ยท 49% Vol Lower Realized Risk LVTX
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 67.0 / 100 (BUY) Higher Composite LVTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AQST vs LVTX Buy Guide
AQST BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 64th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LVTX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AQST nor LVTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.